Conference
Late-breaking abstract: Efficacy and safety of multiple doses of QGEo31 (ligelizumab) versus omalizumab and placebo in inhibiting the allergen induced early asthmatic response
Authors
Gauvreau GM; Boulet L-P; Leigh R; Cockcroft DW; Davis BE; Mayers I; FitzGerald JM; Dahlen B; Watson RM; Milot J
Volume
44
Publisher
EUROPEAN RESPIRATORY SOC JOURNALS LTD
Publication Date
September 1, 2014
Conference proceedings
EUROPEAN RESPIRATORY JOURNAL
ISSN
0903-1936